about
TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial.The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference.Diffusion MRI for prediction of response of rectal cancer to chemoradiation.A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy.A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma.Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis.Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability statusColorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?Proforma-based reporting in rectal cancer.Endorectal ultrasound and magnetic resonance imaging in rectal cancer staging.Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options.Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancerManagement and imaging of low rectal carcinoma.Segmental liver hyperintensity in malignant biliary obstruction on diffusion weighted MRI: associated MRI findings and relationship with serum alanine aminotransferase levelsMagnetic resonance imaging of the low rectum: defining the radiological anatomy.Nodal staging in rectal cancer.Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience.MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer.Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: 'y''u' and 'p' need 'mr' and 'ct'.Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer.A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinomaThe role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.MRI for detection of extramural vascular invasion in rectal cancer.CT staging of colon cancer.A systematic approach to the interpretation of preoperative staging MRI for rectal cancer.Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients.Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer.Nanoparticles in rectal cancer imaging.Chemoradiotherapy response in recurrent rectal cancer.Diagnostic precision of CT in local staging of colon cancers: a meta-analysis.A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era.Rectal cancer: primary staging and assessment after chemoradiotherapy.Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis.Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer.MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience.
P50
Q27853024-F22151DE-33D7-42F3-84A8-36540B396673Q30358472-90F5A334-5553-4E2D-820A-C0E45B01D0B2Q30708318-F3C13078-83AA-474B-9A5C-4725B71C9F99Q33382557-DC79FB7D-C292-45DB-A628-5EE941E083A0Q33396215-3BEC15DF-9FD2-4376-BD03-3D508F09CDE7Q33505114-FBB52EB7-6350-49DA-B739-5D0E605AD309Q33630882-FF58545C-CDA3-4B82-B35A-F46743E3290DQ34207776-FB32E0B0-FAC4-497C-B5BE-64645027E20FQ34256424-3B9BA7FC-BFA8-4876-8E7E-F2C22B17D533Q35025501-0E3FB303-2A1F-4068-B8B4-BECF74C842ADQ35697582-7F56BD26-1B4B-49E0-A7DA-A11248149AFDQ35758360-2C47939C-003D-4E4A-9B4F-3E5F82D46CB7Q35967815-ED49E5BE-2FF7-4BBE-93C3-DB3CB6D42963Q36325506-9A277CE0-C54D-4E6D-87EB-9248CC9C4CF6Q36524363-F76A64F3-8EAB-4393-B977-0A46200D9BB7Q36560538-B81B6339-3394-4342-9547-9968D4A3B469Q36612433-3812E1BD-9543-40D4-BC91-73A017EA348BQ36613720-C67AD42E-B3DE-4CFD-992C-762431394C75Q36626017-A16C040B-DD50-43CC-970A-927E831B5342Q36646705-EC918630-C7BC-46F3-A777-66040C8674BDQ36820078-1640DC73-4437-44C8-8900-B0C177496851Q36871507-431A3ED1-B5F4-4CEB-8234-14B9F7A41DDEQ37225713-B63D7872-7027-4D2A-946F-86114745591EQ37233699-AD197ACD-95B0-418B-B391-B204120B4546Q37305190-C1FB3934-5503-4B28-B9E6-A6E5D5271C7CQ37321492-FA961A44-52CC-4BE4-86B9-2CDABA44C50EQ37329848-5E4FA1A4-FD5D-4EFD-9C1A-EB81667E2AD0Q37355027-113A8CB5-7C08-4E4B-B0F2-C3CFE5B5939CQ37412876-888643E7-C900-4B2E-8A87-AC0DCD93D7A1Q37459563-F0003C56-6924-420F-801C-AEFCF7960489Q37469882-191EB71E-7509-4446-BE70-CFF06E1BED95Q37595254-F4F97AD2-9D75-42E3-87BC-28F4B1CFD013Q37778896-6A30955A-7168-4EFC-8294-09102B623692Q37883691-2F47EEA2-C394-4960-B2DC-D08A8F95E514Q37885511-881DD34A-D12B-411C-BC29-648453BF69ACQ37885517-142A5B87-F407-49FE-81CE-A06876D869F5Q37929520-B84DF076-ACE3-488F-BDBC-E4A0AF317823Q37978211-BEB1AA90-1925-46A2-B993-5C226009CCA6Q37987203-EA60484A-806A-4611-8314-C11B585EE07DQ38045300-AE0D938A-1C5C-4A43-8538-379F883145B6
P50
description
British radiologist and oncologist
@en
British radiologist and oncologist
@en-gb
britische Radiologe und Onkologe
@de
radiolegydd ac oncolegydd Prydeinig
@cy
radiologue et oncologue britannique
@fr
radiólogo y oncólogo británica
@es
wetenschapper
@nl
name
Gina Brown
@af
Gina Brown
@an
Gina Brown
@ang
Gina Brown
@ast
Gina Brown
@bar
Gina Brown
@br
Gina Brown
@ca
Gina Brown
@co
Gina Brown
@cs
Gina Brown
@cy
type
label
Gina Brown
@af
Gina Brown
@an
Gina Brown
@ang
Gina Brown
@ast
Gina Brown
@bar
Gina Brown
@br
Gina Brown
@ca
Gina Brown
@co
Gina Brown
@cs
Gina Brown
@cy
prefLabel
Gina Brown
@af
Gina Brown
@an
Gina Brown
@ang
Gina Brown
@ast
Gina Brown
@bar
Gina Brown
@br
Gina Brown
@ca
Gina Brown
@co
Gina Brown
@cs
Gina Brown
@cy
P106
P1153
8772573900
P21
P31
P496
0000-0002-2336-622X